Clinical Trial Update: Treatment of Androgenetic Alopecia in Males With Theradome™ LH80 PRO [Phase 2]

View source ↗

Summary

An update on a Phase 2 clinical trial evaluating the Theradome LH80 PRO device for treating androgenetic alopecia in men.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Androgenetic Alopecia

Drugs mentioned

• Theradome LH80 PRO

Snippet

Sponsor: Theradome, Inc. | Conditions: Androgenetic Alopecia | Phase 2 | Status: UNKNOWN